Feed Insights Top Reports Pricing

⌘K

14:37:38·1453d

SECFilingvia Quantisnow

SEC Form 10-Q filed by Artivion Inc.

ByQuantisnow·Wall Street's wire, on your screen.

AORT· Artivion Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AORT (Artivion Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

AORT
Artivion Inc.
Health Care

Recent analyst ratings

Apr 10UpdateLadenburg Thalmann$42.00
Aug 13UpdateLadenburg Thalmann$38.79
Jun 17UpdateCanaccord Genuity$35.00
Oct 23UpdateJMP Securities$33.00
Sep 27UpdateLake Street$28.00
Aug 8UpdateLake Street$32.00

Related

PR5d
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results
ANALYST18d
Artivion upgraded by Ladenburg Thalmann with a new price target
PR21d
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
SEC27d
SEC Form DEFA14A filed by Artivion Inc.
SEC27d
SEC Form DEF 14A filed by Artivion Inc.
SEC33d
Amendment: SEC Form SCHEDULE 13G/A filed by Artivion Inc.
INSIDER54d
VP, Chief Accounting Officer Horton Amy sold $34,036 worth of shares (901 units at $37.78) and was granted 7,475 shares, increasing direct ownership by 5% to 139,088 units (SEC Form 4)
INSIDER54d
SVP, General Counsel Holloway Jean F was granted 27,795 shares and sold $485,728 worth of shares (12,805 units at $37.93), increasing direct ownership by 9% to 185,095 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022